Shintaro Kinoshita, Midori Ishii, Jun Ando, Takaharu Kimura, Tomoyuki Yamaguchi, Sakiko Harada,
Fumiyuki Takahashi, Kazutaka Nakashima, Yozo Nakazawa, Satoshi Yamazaki, Koichi Ohshima, Kazuhisa
Takahashi, Hiromitsu Nakauchi, Miki Ando, Successful management of acute graft-versus-host disease with ibrutinib during cord blood
transplantation for germline DDX41-mutated acute myeloid leukemia. Heliyon. 2024 Jan 30;10(2);e24801., doi:10.1016/j.heliyon.2024.e24801.
Shintaro Kinoshita, Midori Ishii, Jun Ando, Takaharu Kimura, Tomoyuki Yamaguchi, Sakiko Harada,
Fumiyuki Takahashi, Kazutaka Nakashima, Yozo Nakazawa, Satoshi Yamazaki, Koichi Ohshima, Kazuhisa
Takahashi, Hiromitsu Nakauchi, Miki Ando,
Rejuvenated iPSC-derived GD2-directed CART cells harbor robust cytotoxicity against small cell lung
cancer.Cancer research communications. 2024 Feb 21, doi:10.1158/2767-9764.CRC-23-0259.
Hajime Yasuda, Naoko Kaga, Hikari Taka, Tomonori Ochiai, Tomohito Yamana, Yoshiki Miura, Midori Ishii,
Makoto Sasaki, Jun Ando, Miki Ando,
Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma.
Cancer chemotherapy and pharmacology. 2024 Mar;93(3);265-268., doi:10.1007/s00280-023-04593-w.
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Michiko Ichii, Takeshi Okatani, Hiromi Omura, Kei
Nakajima, Makoto Sasaki, Jun Ando, Tomoiku Takaku, Michiaki Koike, Koh Izumiyama, Junji Hiraga, Tomofumi
Yano, Kensuke Usuki, Eiichi Ohtsuka, Kenji Yokoyama, Tatsuo Oyake, Naoki Takahashi, Tetsuya Nishida,
Takafumi Nakao, Yasutaka Fukuda, Takashi Akasaka, Atsuko Mugitani, Miki Ando, Norio Komatsu,Real-world
status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms
in Japan.,Hematology (Amsterdam, Netherlands). 2024 Dec;29(1);2340149.,
doi:10.1080/16078454.2024.2340149.
Tomonori Ochiai, Hajime Yasuda, Hisaya Akiba, Karin Ashizawa, Erina Hosoya, Jun Ando, Sachiko Miyake,
Miki Ando, Ectopic band 3 expression as a cause of mature ovarian teratoma-associated secondary
autoimmune hemolytic anemia. ,International journal of laboratory hematology. 2024 Apr 02;, doi:10.1111/ijlh.14276."
Yasuhiro Homma, Takuma Yamasaki, Ken Tashiro, Yoshiki Okada, Yuichi Shirogane, Taiji Watari, Koju
Hayashi, Tomonori Baba, Kazufumi Nagata, Naotake Yanagisawa, Hiroshi Ohtsu, Naho Fujiwara, Jun Ando, Ken
Yamaji, Naoto Tamura, Muneaki Ishijima, Autologous concentrated bone marrow injection for precollapse
osteonecrosis of the femoral head concurrent with contralateral total hip arthroplasty: protocol for a
clinical trial., BMJ open. 2024 May 08;14(5);e082243. pii: e082243., DOI: 10.1136/bmjopen-2023-082243
Yoshiki Furukawa, Jun Ando, Midori Ishii, Shintaro Kinoshita, Ayaka Goto, Kota Tachibana, Yoko Azusawa,
Takao Kato, Norihide Izumi, Erina Hosoya, Ayana Uchimura, Tadaaki Inano, Shuichi Shirane, Yutaka
Tsukune, Tomoiku Takaku, Yasuharu Hamano, Miki Ando, l-asparaginase monotherapy as an encouraging
approach towards acute fulminant chronic active Epstein-Barr virus infection.,British journal of
haematology. 2024 Jul 19; doi: 10.1111/bjh.19652., DOI: 10.1111/bjh.19652
Mendamar Ravzanaadii, Yuki Horiuchi, Yosuke Iwasaki, Akihiko Matsuzaki, Kimiko Kaniyu, Jing Bai, Aya
Konishi, Jun Ando, Miki Ando, Yoko Tabe, Robustness assessment of an automated AI-based white blood cell
morphometric analysis system using different smear preparation methods., International journal of
laboratory hematology. 2024 Jul 25; doi: 10.1111/ijlh.14350., DOI: 10.1111/ijlh.14350
Erina Hosoya, Jun Ando, Shintaro Kinoshita, Yoshiki Furukawa, Yuko Toyoshima, Yoko Azusawa, Toru
Mitsumori, Eriko Sato, Hina Takano, Yutaka Tsukune, Naoki Watanabe, Tomoiku Takaku, Hajime Yasuda,
Yasuharu Hamano, Makoto Sasaki, Shuko Nojiri, Midori Ishii, Miki Ando, Eleven cases of laryngeal edema
after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric
antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas., Haematologica. 2024 Oct
17; doi: 10.3324/haematol.2024.286169., Haematologica. 2024 Oct 17; doi: 10.3324/haematol.2024.286169.
Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Dai Maruyama,
Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, Michihiro Hidaka, Youngil Koh, Hisashi Kato, Toshiki Uchida,
Deok Hwan Yang, Kenji Ishitsuka, Kenichi Ishizawa, Jin Seok Kim, Hong Ghi Lee, Hironobu Minami, Hyeon
Seok Eom, Mitsutoshi Kurosawa, Jae Hoon Lee, Jong Seok Lee, Won Sik Lee, Hirokazu Nagai, Takero Shindo,
Dok Hyun Yoon, Shinichiro Yoshida, Mireille Gillings, Hiroshi Onogi, Kensei Tobinai, Long-term efficacy
and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final
analysis of phase IIb results., Haematologica. 2024 Oct 01;109(10);3357-3362. doi:
10.3324/haematol.2023.283992.
Shoko Sato, Midori Ishii, Kota Tachibana, Yoshiki Furukawa, Tokuko Toyota, Shintaro Kinoshita, Yoko
Azusawa, Jun Ando, Miki Ando: Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma
cell line with scRNA-seq analysis. Exp Hematol. 2024 Feb;130:104132. doi: 10.1016/j.exphem.2023.11.006.
Shintaro Kinoshita, Midori Ishii, Jun Ando, Takaharu Kimura, Tomoyuki Yamaguchi, Sakiko Harada, Fumiyuki
Takahashi, Kazutaka Nakashima, Yozo Nakazawa, Satoshi Yamazaki, Koichi Ohshima, Kazuhisa Takahashi,
Hiromitsu Nakauchi, and Miki Ando:Rejuvenated iPSC-derived GD2-directed CART cells harbor robust
cytotoxicity against small cell lung cancer. Cancer Res Commun. 2024 Mar 11;4(3):723-737. doi:
10.1158/2767-9764.
Ayana Uchimura,Hajime Yasuda,Hiroko Onagi,Tadaaki Inano,Shuichi Shirane,Midori Ishii,Yoko
Azusawa,Yasuharu Hamano,Hidetaka Eguchi,Masami Arai,Jun Ando,Miki Ando: Successful management of
acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline
DDX41-mutated acute myeloid leukemia. Heliyon. 2024 Jan 17;10(2):e24801. doi:
10.1016/j.heliyon.2024.e24801.
Yosuke Mori, Marito Araki, Soji Morishita, Misa Imai, Yoko Edahiro, Masafumi Ito, Tomonori Ochiai, Shuichi
Shirane, Yoshinori Hashimoto, Hajime Yasuda, Jun Ando, Miki Ando, Norio Komatsu Clinical features of acquired
erythrocytosis: Low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients
Cancer medicine. 2023 Jan;12(2);1079-1089. doi: 10.1002/cam4.4958.
Hajime Yasuda, Yasunobu Hoshino, Jun Ando, Mayu Miyachi, Monami Osawa, Nobutaka Hattori, Miki Ando Vitamin B6 Deficiency Polyneuropathy and Dermatitis The American journal of medicine. 2023 Jan;136(1);e10-e11. doi: 10.1016/j.amjmed.2022.09.009.
Hajime Yasuda, Jun Ando, Sayako Yoshida, Yasunori Ota, Norio Komatsu, Miki Ando Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic
Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination
Alone in Two Cases Internal medicine (Tokyo, Japan). 2023 Feb 15;62(4);601-604. doi: 10.2169/internalmedicine.0130-22.
Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Masahiro Yokoyama,
Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, Michihiro Hidaka, Youngil Koh, Hirohiko Shibayama, Toshiki Uchida,
Deok Hwan Yang, Kenji Ishitsuka, Kenichi Ishizawa, Jin Seok Kim, Hong Ghi Lee, Hironobu Minami, Hyeon Seok Eom,
Mitsutoshi Kurosawa, Jae Hoon Lee, Jong Seok Lee, Won Sik Lee, Hirokazu Nagai, Takero Shindo, Dok Hyun Yoon,
Shinichiro Yoshida, Mireille Gillings, Hiroshi Onogi, Kensei Tobinai Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb
results Haematologica. 2023 Mar 01;108(3);811-821. doi: 10.3324/haematol.2022.280996.
Jun Ando, Yoshiki Furukawa, Midori Ishii, Shintaro Kinoshita, Shoko Sato, Yutaka Tsukune, Hajime Yasuda,
Tomoiku Takaku, Yasuharu Hamano, Makoto Sasaki, Miki Ando, “Venetoclax combinations in untreated and R/R AML
with single-cell RNA-seq, TP53-mutated patients.” The 85th
Annual Meeting of the Japanese Society of Hematology, Tokyo, 2023年10月13 - 15日 第85回日本血液学会学術集会(口演)
Midori Ishii, Shintaro Kinoshita, Kensuke Yanashima, Shoko Sato, Hajime Yasuda, Jun Ando, Jun Teruya, Miki
Ando, ” Three cases of postoperative hemorrhage due to reduced factor XIII activity with F13A1 variants.” The
85th
Annual Meeting of the Japanese Society of Hematology, Tokyo, 2023年10月13〜15日 第85回日本血液学会学術集会(口演)
Ryota Imanaka, Yuna Katsuoka, Nobuhiko Uoshima, Satoru Hara, Jun Ando, Tatsunori Goto, Shuichi Ota, Goichi
Yoshimoto, Akihito Matsuoka, Hideyuki Hashiba, Tetsuo Morita, Atsuko Tsutsui, Hiroki Numata, “Multicenter study
of real-world experience of venetoclax for newly diagnosed AML in Japan (VENUS).” The 85th
Annual Meeting of the Japanese Society of Hematology, Tokyo, 2023年10月13〜15日 第85回日本血液学会学術集会(口演)
Hajime Yasuda, Norio Komatsu, Jun Ando, Miki Ando
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations
Clinical lymphoma, myeloma & leukemia. 2022 11;22(11);805-811. Pii: S2152-2650(22)00226-9.
Kazuhide Iizuka, Soji Morishita, Yuji Nishizaki, Yoshikazu Iizuka, Noriyoshi Iriyama, Tomonori Ochiai, Naotake Yanagisawa, Hajime Yasuda, Jun Ando, Akihiko Gotoh, Masami Takei, Yoshihiro Hatta, Hideki Nakamura, Tomohiro Nakayama, Norio Komatsu
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet counts
European journal of haematology. 2022 Dec;109(6);779-786. doi: 10.1111/ejh.13866
Terumi Baba, Yoshinori Hashimoto, Hajime Yasuda, Marito Araki, Yoko Edahiro, Soji Morishita, Tomonori Ochiai, Shuichi Shirane, Jun Ando, Norio Komatsu
Validation and reliability of current guidelines for the treatment of essential thrombocythemia under real-world clinical settings in Japan
Hematology (Amsterdam, Netherlands). 2022 Dec;27(1);157-166. doi: 10.1080/16078454.2021.2022848.
Furukawa Y, Ando J, Ishii M, Kinoshita S, Ando M, A novel extranodal NK/T-cell lymphoma, nasal type cell line, ENKL-J1, 第84回日本血液学会学術集会, 福岡, 2022年10月15日
Iwakiri M, Nagata Y, Sheng J, Marumo A, Sakaguchi M, Arai K, Kitano T, Miyata M, Wakita S, Kuroda J, Nagao Y, Tadokoro J, Uchiyama H, Kimura S, Motomura S, Sato E, Ogata M, Mitsuhashi K, Ando J, Kanda J, Kawata E, Doki N, Mori S, Uoshima N, Kako S, Kanda
Y, Shono K, Satake A, Yamaguchi H, The clinical and genetic features of Japanese de novo AML with IDH1/2 and SRSF2 mutations., 第84回日本血液学会学術集会, 福岡, 2022年10月16日
Morishita S, De Marchi F, Okuda M, Imai M, Baba T, Mori Y, Furuya C, Ogata S, Yang Y, Ando J, Ando M, Araki M, Komatsu N, Clinical relevance of CREB3L1 expression in Ph-negative MPN, 第84回日本血液学会学術集会, 福岡, 2022年10月14日(金)~16日(日)
Sheng J, Nagata Y, Marumo A, Sakaguchi M, Arai K, Kitano T, Miyata M, Wakita S, Kuroda J, Nagao Y, Tadokoro J, Uchiyama H, Kimura S, Motomura S, Sato E, Ogata M, Mitsuhashi K, Ando J, Kanda J, Kawata E, Doki N, Mori S, Uoshima N, Kako S, Kanda Y, Shono
K, Satake A, Yamaguchi H, Clinical impact of IDH1/2 mutations in AML patients treated with Venetoclax., 第84回日本血液学会学術集会, 福岡, 2022年10月14日